AES(AES)
Search documents
5 High-Yield Infrastructure Stocks Looking Cheap On The Dip
Seeking Alpha· 2025-01-04 12:05
Infrastructure Sector Outlook - The infrastructure sector (UTF) is expected to experience significant growth in the coming years [1] - A major driver of this growth is the increasing demand for clean and reliable electrical power [1] Investment Service Overview - The investment service is the fastest-growing high-yield-seeking platform on Seeking Alpha [2] - It has a perfect 5/5 rating based on 180 reviews [2] - Members are benefiting from high-yielding strategies offered by the service [2] - A 2-week free trial is available at the lowest rate ever offered, with no charges during the trial period [1][2]
Why AES (AES) is a Top Value Stock for the Long-Term
ZACKS· 2024-12-16 15:41
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style ...
3 Stocks to Keep an Eye on After Dividend Hike Announcement
ZACKS· 2024-12-12 14:25
The Wall Street rally appears to have paused after a month. Major indexes have retreated over the past few sessions after hitting record closing highs over the past month, as the post-election euphoria appears to be fizzling out.Also, geopolitical tensions coupled with concerns over the recent jump in inflation have somewhat dented investors’ confidence. Given this situation, cautious investors looking for a steady income and protecting their capital may look to hold or buy dividend-paying stocks.Three such ...
Here's Why AES (AES) is a Strong Momentum Stock
ZACKS· 2024-12-11 15:50
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores a ...
My Top 2 Stock Picks For A 2025 Rebound
Seeking Alpha· 2024-12-11 14:32
This is one of my favorite times of the year for investing in stocks, and it's primarily because there are bargains to be had due to tax-loss selling. Many investors have big gains in certain stocks andLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: @Hawkinvest1Analyst’s Disclosure: ...
AES Announces Pricing of $500 Million Fixed-to-Fixed Reset Rate Junior Subordinated Notes in Public Offering
Prnewswire· 2024-12-04 21:30
ARLINGTON, Va., Dec. 4, 2024 /PRNewswire/ -- The AES Corporation (NYSE: AES) ("AES") announced today the pricing of $500 million aggregate principal amount of its 6.950% fixed-to-fixed reset rate junior subordinated notes due 2055 (the "Notes"). The closing of the offering of the Notes is expected to occur, subject to certain customary closing conditions, on December 6, 2024 (T+2).AES intends to use the net proceeds from the proposed offering to repay existing indebtedness, including borrowings under the re ...
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
GlobeNewswire News Room· 2024-12-04 21:05
RNS System to be featured in over 70 scientific presentations and posters Pre-book a demonstration in the NeuroPace Tech Suite to see the latest innovations of the RNS System which simplify the treatment experience for physicians and patients NeuroPace’s Booth #2119 MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- December 4, 2024 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will have a ...
AES Announces Public Offering of Fixed-to-Fixed Reset Rate Junior Subordinated Notes
Prnewswire· 2024-12-04 14:25
ARLINGTON, Va., Dec. 4, 2024 /PRNewswire/ -- The AES Corporation (NYSE: AES) ("AES") announced today its intention to offer, subject to market and other conditions, fixed-to-fixed reset rate junior subordinated notes (the "Notes") in a registered public offering.AES intends to use the net proceeds from the proposed offering to repay existing indebtedness, including borrowings under the revolving facility of its senior credit facility, and for general corporate purposes.J.P. Morgan Securities LLC, Wells Farg ...
Here's Why AES (AES) is a Strong Value Stock
ZACKS· 2024-11-29 15:40
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
GlobeNewswire News Room· 2024-11-25 13:30
Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around mental health and comorbidity burdens of FOSNew pre-clinical data from the Company’s Nav1.1 program VANCOUVER, British Columbia and BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, t ...